Henry Bernard, Ph.D
About Henry Bernard, Ph.D
Henry Bernard, Ph.D., is the Senior Training Manager Immuno-Oncologie at Bristol-Myers Squibb in Rueil-Malmaison, Île-de-France, France. He has extensive experience in medical and scientific roles, having worked at Sanofi, Bayer HealthCare, Danone, and Inserm U859, and holds multiple degrees in medicine, immunology, and biotechnology management.
Company
Henry Bernard, Ph.D, currently works at Bristol-Myers Squibb as a Senior Training Manager in Immuno-Oncologie, located in Rueil-Malmaison, Île-de-France, France. His role encompasses various aspects of training and development within the immuno-oncology sector, focusing on providing support to Medical Science Liaisons and continuously refining training materials for ongoing educational needs.
Previous Roles
Henry Bernard has held multiple roles across various companies. He worked at Sanofi as Chef de Projet Médical Lipidologie for three years from 2014 to 2017 in the Paris region. At Bayer HealthCare, he served as Chef de Produit Junior – Oncologie / Hémophilie / Hypertension Artérielle Pulmonaire from 2013 to 2014 for 9 months in Loos, France. Before that, he was an Ingénieur de recherche at Danone for four years starting in 2008 in the Lille region. Additionally, he worked as an Ingénieur d'étude at Inserm U859, Biothérapie du diabète, from 2007 to 2008 in Lille, France.
Education and Expertise
Henry Bernard holds multiple degrees in the medical and biotechnology fields. He earned a Diplôme Universitaire de Carcinologie Thoracique Intégrée from Université Paris-Saclay between 2020 and 2021, and an MBA in Management des Biotechnologies from IONIS-STM from 2012 to 2013. Henry also achieved a Doctorat in Sciences de la vie, Immunologie from Université de Lille 2 from 2008 to 2011, and a Master 2 in Biologie, Physiologie, Physiopathologie from Université Paris Cité from 2007 to 2008.
Publications and Presentations
Henry Bernard has three publications in Immunology and has actively presented his research at international conferences. His work often involves collaboration with Key Opinion Leaders (KOLs) and he has contributed to the development and dissemination of new findings in the field.
Clinical and Medical Projects
Henry Bernard has been deeply involved in various clinical and medical projects. He has experience launching medications, implementing, and monitoring clinical studies, and developing campaigns, seminars, and PMMV. His contributions include writing clinical study protocols, managing boards with scientific committees, selecting Contract Research Organizations (CROs), monitoring budgets, and supporting MSLs by creating training materials. Notably, he has been involved in the launch of an anti-PCSK9 treatment for familial hypercholesterolemia.